Rising Pharma Holding, Inc. 2025-01-15 Health serious FDA
Health · FDA · Recall #FDA-D-0188-2025
Duloxetine Delayed-Release Capsules USP 30 mg, a) 30 count (NDC 57237-018-30) and b) 1000… Recall
Issued January 15, 2025 · Rising Pharma Holding, Inc.
In January 2025, Rising Pharma Holding, Inc. recalled the Duloxetine Delayed-Release Capsules USP 30 mg, a) 30 count (NDC 57237-018-30) and b) 1000…, a serious health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
CGMP Deviations; Presence of N-nitroso-duloxetine impurity above recommended interim limit.
What you should do
- 1 Stop using Duloxetine Delayed-Release Capsules USP 30 mg, a) 30 count (NDC 57237-018-30) and b) 1000… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Rising Pharma Holding, Inc. to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Rising Pharma Holding, Inc.
- Category
- Health
- Recall date
- January 15, 2025
- Units affected
- Not reported
- Sold at
- Nationwide
- Recall number
- FDA-D-0188-2025
- Made in
- United States
- Issuing agency
- FDA
In context
- Rising Pharma Holding, Inc. has 3 recalls in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 691st Health recall we've logged in 2025.